Identity
HGNC
LOCATION
13q14.2
LOCUSID
ALIAS
ALT1,BCMSUN,DLB2,LEU2,LINC00022,MIR15AHG,NCRNA00022,RFP2,RFP2OS,TRIM13OS
FUSION GENES
Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
NCBI: 8847
MIM: 605766
HGNC: 13748
Ensembl: ENSG00000231607
Variants:
dbSNP: 8847
ClinVar: 8847
TCGA: ENSG00000231607
COSMIC: DLEU2
RNA/Proteins
Expression (GTEx)
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 37161284 | 2024 | LncRNA DLEU2 contributes to Taxol resistance of gastric cancer cells through regulating the miR-30c-5p-LDHA axis. | 1 |
| 38305289 | 2024 | DLEU2/EZH2/GFI1 Axis Regulates the Proliferation and Apoptosis of Human Bone Marrow Mesenchymal Stem Cells. | 0 |
| 37161284 | 2024 | LncRNA DLEU2 contributes to Taxol resistance of gastric cancer cells through regulating the miR-30c-5p-LDHA axis. | 1 |
| 38305289 | 2024 | DLEU2/EZH2/GFI1 Axis Regulates the Proliferation and Apoptosis of Human Bone Marrow Mesenchymal Stem Cells. | 0 |
| 36209036 | 2023 | Long noncoding RNA DLEU2 regulates the progression of Wilm's tumor via miR-539-3p/HOXB2 axis. | 0 |
| 37095423 | 2023 | Deleted in lymphocytic leukemia 2 (DLEU2): a possible biomarker that holds promise for future diagnosis and treatment of cancer. | 0 |
| 36209036 | 2023 | Long noncoding RNA DLEU2 regulates the progression of Wilm's tumor via miR-539-3p/HOXB2 axis. | 0 |
| 37095423 | 2023 | Deleted in lymphocytic leukemia 2 (DLEU2): a possible biomarker that holds promise for future diagnosis and treatment of cancer. | 0 |
| 35075115 | 2022 | E2F transcription factor 2-activated DLEU2 contributes to prostate tumorigenesis by upregulating serum and glucocorticoid-induced protein kinase 1. | 11 |
| 35468741 | 2022 | LINC00022 acts as an oncogene in colorectal cancer progression via sponging miR-375-3p to regulate FOXF1 expression. | 1 |
| 35611845 | 2022 | Deleted in lymphocytic leukemia 2 induces retinoic acid receptor beta promoter methylation and mitogen activated kinase-like protein activation to enhance viability and mobility of colorectal cancer cells. | 3 |
| 35736813 | 2022 | LncRNA DLEU2 silencing impedes the migration, invasion and EMT in gastric cancer cell by suppressing PI3K/AKT signaling pathway. | 1 |
| 35775826 | 2022 | DLEU2 modulates proliferation, migration and invasion of platelet-derived growth factor-BB (PDGF-BB)-induced vascular smooth muscle cells (VSMCs) via miR-212-5p/YWHAZ axis. | 2 |
| 36277988 | 2022 | lncRNA DLEU2 Accelerates Oral Cancer Progression via miR-30a-5p/RAP1B Axis to Regulate p38 MAPK Signaling Pathway. | 2 |
| 35075115 | 2022 | E2F transcription factor 2-activated DLEU2 contributes to prostate tumorigenesis by upregulating serum and glucocorticoid-induced protein kinase 1. | 11 |
Citation
Dessen P
DLEU2 (deleted in lymphocytic leukemia 2)
Atlas Genet Cytogenet Oncol Haematol. 2003-02-01
Online version: http://atlasgeneticsoncology.org/gene/40331
